Due to the crucial role of HIF-1 for tumor growth in HCC, HIF-1 becomes a novel molecular target for gene therapy using nucleic acids, such as DNA, siRNA, shRNA and antisense oligonucleotides (ASON). Here, HIF1A is linked to hepatocellular carcinoma.